Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS · Delayed Price · Currency is USD
1.400
0.00 (0.00%)
Oct 7, 2026, 4:00 PM EST
Raphael Pharmaceutical Market Cap
Raphael Pharmaceutical has a market cap or net worth of $28.25 million as of October 8, 2026. It is the 34,607th most valuable company in the world and the 5,049th biggest in the United States. Its market cap has increased by 259.81% in one year.
Market Cap
28.25M
Enterprise Value
28.28M
Revenue
n/a
Global Rank
Country Rank
#5,049 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 5, 2023, Raphael Pharmaceutical's market cap has decreased from 34.37M to 28.25M, a decrease of -17.82%. That is a compound annual growth rate of -5.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 28.25M | 2.80% |
| Dec 24, 2025 | 27.48M | -20.06% |
| Jan 5, 2023 | 34.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sofgen Pharma | 43.07M |
| Cyphaira | 39.17M |
| High Sierra Technologies | 28.98M |
| Radnostix | 26.46M |
| Earth Science Tech | 26.23M |
| MariMed | 25.79M |
| Healthy Extracts | 15.48M |
| Bio Essence | 15.07M |